Document Detail

Effects of magnesium sulfate in a newborn piglet meconium aspiration model.
MedLine Citation:
PMID:  11002877     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To examine the hemodynamic effects of magnesium sulfate (MgSO4) in a neonatal model of meconium aspiration syndrome. DESIGN: A prospective animal study. PATIENTS AND PARTICIPANTS: Eight anesthetized neonatal piglets. METHODS: Animals were instrumented under fentanyl anesthesia for the determination of pulmonary and systemic blood pressures and cardiac index. A model of meconium aspiration was produced by instilling 6 to 7 ml of 20% fresh human meconium in normal saline down the endotracheal tube, resulting in hypoxemia (mean arterial O2 saturation 73 SD, 10%), respiratory acidosis (mean pH 7.08, SD 0.04; PaCO2 89, SD 2 torr), and pulmonary arterial hypertension (mean pulmonary artery pressure 52 SD, 5 mm Hg). A total of four aliquots of MgSO4 (25 mg/kg equivalent to 0.1 mM/kg of magnesium) were administered intravenously to five animals (total of 100 mg/kg MgSO4). Three animals served as controls and did not receive MgSO4. RESULTS: Each dose of MgSO4 was associated with a transient decrease in heart rate, cardiac index, pulmonary and systemic arterial pressures, and SaO2, followed by a partial gradual recovery of all these variables within 2 to 3 minutes. According to measurements taken after MgSO4 therapy, there was a significant decrease in arterial saturations (from 73 SD (10%) to 63 SD (13%); p < 0.05), mean systemic blood pressure (from 77 SD (16 mm Hg) to 74 SD (15 mm Hg); p < 0.05) and pulmonary artery pressure (to 52 SD (5 mm Hg); p < 0.05). The ratio between pulmonary and systemic vascular resistance was not significantly affected by MgSO4 therapy. There were no changes in the control animals. CONCLUSION: The administration of magnesium sulfate is associated with increased hypoxemia in this model of meconium aspiration syndrome, probably because of worsening ventilation perfusion mismatch. These data do not provide any physiological support for the use of MgSO4 in the neonate with meconium aspiration and pulmonary hypertension and suggest that this agent should be used cautiously, if at all, in such situations.
K J Barrington; C A Ryan; N N Finer
Related Documents :
3698227 - Pulmonary vascular effects of hydralazine in a canine preparation of pulmonary thromboe...
3479617 - Systemic and pulmonary haemodynamics in normal neonatal foals.
6148467 - Vasodilator therapy for primary pulmonary hypertension.
24852687 - New insights into salt-sensitive hypertension.
12623507 - Reproducibility of non-invasive urodynamics, using the cuff-uroflow, for the diagnosis ...
20036967 - Deregulation of rgs2 in cardiovascular diseases.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of perinatology : official journal of the California Perinatal Association     Volume:  20     ISSN:  0743-8346     ISO Abbreviation:  J Perinatol     Publication Date:  2000 Sep 
Date Detail:
Created Date:  2001-01-02     Completed Date:  2001-01-11     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8501884     Medline TA:  J Perinatol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  373-8     Citation Subset:  IM    
Department of Pediatrics, University of Alberta, Edmonton, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Animals, Newborn
Anoxia / chemically induced
Blood Pressure / drug effects
Infant, Newborn
Magnesium Sulfate / adverse effects,  therapeutic use*
Meconium Aspiration Syndrome / drug therapy*,  physiopathology
Oxygen / blood
Pulmonary Artery / drug effects,  physiopathology
Treatment Failure
Reg. No./Substance:
7487-88-9/Magnesium Sulfate; 7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Differential markers for regionalization.
Next Document:  Treatment decisions for newborns at the threshold of viability: an ethical dilemma.